Low-dose Desmopressin Orally Disintegrating Tablet: Suggested Clinically Meaningful Benefit in Patients with Nocturia Due to Nocturnal Polyuria.
Sign Up to like & getrecommendations! Published in 2018 at "European urology focus"
DOI: 10.1016/j.euf.2018.11.001
Abstract: BACKGROUND Clinical benefit has not been evaluated much in patients with nocturia. OBJECTIVE To assess the clinical benefit of desmopressin orally disintegrating tablet (ODT) in women (25μg) and men (50μg) with nocturia due to nocturnal… read more here.
Keywords: clinical benefit; benefit; patients nocturia; desmopressin orally ... See more keywords
Efficacy and safety of desmopressin orally disintegrating tablets 25 and 50 μg in male patients with nocturia: A Japanese real‐world multicenter clinical study
Sign Up to like & getrecommendations! Published in 2022 at "LUTS: Lower Urinary Tract Symptoms"
DOI: 10.1111/luts.12459
Abstract: To clarify Japanese real‐world clinical data on the use of desmopressin 25 and 50 μg orally disintegrating tablets (ODT) for male patients with nocturia and evaluate the predictive factors to improve nighttime frequency. read more here.
Keywords: orally disintegrating; japanese real; desmopressin orally; male patients ... See more keywords